Whittier Trust Co. of Nevada Inc. Has $2.32 Million Holdings in Avantor, Inc. (NYSE:AVTR)

Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 5.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 109,921 shares of the company’s stock after buying an additional 5,483 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Avantor were worth $2,315,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB increased its position in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after buying an additional 625 shares during the last quarter. Smartleaf Asset Management LLC increased its position in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after buying an additional 830 shares during the last quarter. Global Retirement Partners LLC grew its position in shares of Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. grew its position in shares of Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after purchasing an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC acquired a new position in shares of Avantor in the fourth quarter valued at approximately $65,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on AVTR. Citigroup decreased their target price on Avantor from $22.00 to $18.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Barclays decreased their target price on Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. UBS Group reaffirmed a “neutral” rating and issued a $25.00 target price (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Morgan Stanley decreased their target price on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Finally, Cowen reissued a “buy” rating on shares of Avantor in a research report on Tuesday. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and an average target price of $25.50.

Avantor Stock Up 2.0 %

NYSE AVTR opened at $16.61 on Friday. The business has a fifty day moving average price of $18.98 and a two-hundred day moving average price of $21.74. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. Avantor, Inc. has a fifty-two week low of $15.37 and a fifty-two week high of $28.00. The stock has a market capitalization of $11.31 billion, a PE ratio of 15.97, a PEG ratio of 1.55 and a beta of 1.30.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the previous year, the firm earned $0.22 earnings per share. Equities analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP James Bramwell sold 3,758 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. This represents a 4.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.30% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.